First-line integrase inhibitors for HIV-prices versus benefits
- PMID: 27658868
- DOI: 10.1016/S2352-3018(16)30154-0
First-line integrase inhibitors for HIV-prices versus benefits
Comment on
-
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.Lancet HIV. 2016 Nov;3(11):e510-e520. doi: 10.1016/S2352-3018(16)30091-1. Epub 2016 Sep 6. Lancet HIV. 2016. PMID: 27658869
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical